Elucida Oncology Logo.jpg
Elucida Oncology Submits IND Application for ELU-001 for the Treatment of Cancers Overexpressing Folate-Receptor Alpha
July 19, 2021 10:00 ET | Elucida Oncology, Inc
MONMOUTH JUNCTION, N.J., July 19, 2021 (GLOBE NEWSWIRE) -- Elucida Oncology, a biotechnology company pioneering the next frontier in targeted cancer therapy, announced today that it has submitted an...
Elucida Oncology Logo.jpg
Elucida Oncology Announces Three Key Additions to Its Board of Directors and the Appointment of Robert Essner as Chairman of the Board
April 29, 2021 11:00 ET | Elucida Oncology, Inc
MONMOUTH JUNCTION, N.J., April 29, 2021 (GLOBE NEWSWIRE) -- Elucida Oncology, a biotechnology company pioneering the next frontier in targeted cancer therapy, announced today three key additions to...
Elucida Oncology Logo.jpg
Elucida Oncology to Present Preclinical Data on ELU001 at the American Association for Cancer Research Annual Meeting
March 29, 2021 10:15 ET | Elucida Oncology, Inc
MONMOUTH JUNCTION, N.J., March 29, 2021 (GLOBE NEWSWIRE) -- Elucida Oncology, a biotechnology company pioneering the next frontier in targeted cancer therapy, announced today that an abstract...
Elucida Oncology Logo.jpg
Elucida Oncology Closes $44 Million Series A-1 Financing
January 12, 2021 09:15 ET | Elucida Oncology, Inc
MONMOUTH JUNCTION, N.J., Jan. 12, 2021 (GLOBE NEWSWIRE) -- Elucida Oncology, a biotechnology company pioneering the next frontier in targeted cancer therapy, announced today it has closed a $44...
Elucida Oncology Logo.jpg
Elucida Oncology to Present at the 39th Annual J.P. Morgan Healthcare Conference
January 07, 2021 14:00 ET | Elucida Oncology, Inc
Elucida will also participate in the BIO Partnering @ JPM event MONMOUTH JUNCTION, N.J., Jan. 07, 2021 (GLOBE NEWSWIRE) -- Elucida Oncology, a biotechnology company pioneering the next frontier in...
Elucida Oncology Logo.jpg
Elucida Oncology Appoints Dr. Eliel Bayever as Chief Medical Officer
October 01, 2020 15:32 ET | Elucida Oncology, Inc
MONMOUTH JUNCTION, N.J., Oct. 01, 2020 (GLOBE NEWSWIRE) -- Elucida Oncology, a biotechnology company pioneering the next frontier in targeted cancer therapy, announced today the appointment of Dr....